Schlagwörter
Netherlands
3
acenocoumarol
3
adult
3
aged
3
anticoagulant therapy
3
apixaban
3
article
3
clinical outcome
3
controlled clinical trial (topic)
3
controlled study
3
cost effectiveness analysis
3
cost-effectiveness
3
drug cost
3
embolism prevention
3
female
3
human
3
lifelong treatment
3
low molecular weight heparin
3
major clinical study
3
male
3
non-vitamin K oral anticoagulants
3
phenprocoumon
3
priority journal
3
quality adjusted life year
thrombosis prevention
3
venous thromboembolism
3
venous thrombosis
3